What We're Reading: Page 121
Industry reads hand-picked by our editors
Mar 30, 2022
Mar 29, 2022
Mar 28, 2022
Mar 25, 2022
-
The New York Times
F.D.A.’s Accelerated Drug Approvals Come Under Scrutiny
-
The Daily Item
Merck to close Cherokee plant in Riverside, impacting 300 full-time workers
-
Reuters
Moderna raises full-year COVID vaccine sales forecast to $21 billion
-
STAT
Dr. Glaucomflecken, the internet’s funniest doctor, is in on the joke
Mar 24, 2022
-
Fierce Biotech
Merck's CMO follows Roger Perlmutter to Eikon
-
Nature
Undisclosed industry payments rampant in drug-trial papers
-
Politico
Biden administration eyeing booster shot recommendation within weeks
-
Endpoints News
Drug discovery specialists at Ligand take their antibody biz public via SPAC, aiming to build $850M company
Mar 23, 2022
Mar 22, 2022
-
Financial Times
Finance, culture, talent: why Europe struggles to commercialise its biotech expertise
-
Reuters
Former Takeda vaccine chief to lead new COVID antiviral venture Aerium
-
Evaluate Vantage
Biohaven's high-risk bet
-
Bloomberg
Pfizer to Sell Up to 4 Million Doses of Covid Drug Paxlovid to 95 Nations
Previous
